CNS Metastases Needn't Rule Out Trial Inclusion [News in Brief]

Guidelines aim to open more drug studies to patients with central nervous system tumors, increase efficacy data.

from Cancer via ola Kala on Inoreader http://ift.tt/2DnA7Xr
via IFTTT